HWM
IDXX icon

HB Wealth Management’s Idexx Laboratories IDXX Stock Holding History

HB Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Sell
4,167
-110
-3% -$61.7K 0.01% 450
2026
Q1 		$2.4M Buy
4,277
+138
+3% +$88.5K 0.02% 386
2025
Q4 		$2.8M Buy
4,139
+189
+5% +$129K 0.02% 347
2025
Q3 		$2.52M Buy
3,950
+328
+9% +$199K 0.02% 372
2025
Q2 		$1.94M Sell
3,622
-202
-5% -$96.6K 0.02% 382
2025
Q1 		$1.61M Buy
3,824
+1,585
+71% +$688K 0.01% 428
2024
Q4 		$926K Buy
2,239
+11
+0.5% +$4.83K 0.01% 427
2024
Q3 		$1.13M Buy
2,228
+167
+8% +$81.1K 0.01% 367
2024
Q2 		$1M Sell
2,061
-150
-7% -$75.3K 0.01% 369
2024
Q1 		$1.19M Buy
2,211
+911
+70% +$498K 0.02% 322
2023
Q4 		$722K Sell
1,300
-74
-5% -$34.7K 0.01% 376
2023
Q3 		$601K Buy
1,374
+179
+15% +$89.3K 0.01% 394
2023
Q2 		$600K Buy
1,195
+53
+5% +$25.4K 0.01% 377
2023
Q1 		$571K Buy
1,142
+106
+10% +$50.7K 0.01% 382
2022
Q4 		$423K Buy
+1,036
New +$402K 0.01% 432

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

HB Wealth Management's IDXX Position: Q2 2026 in Review

HB Wealth Management reduced its Idexx Laboratories (IDXX) stake by 2.6% in Q2 2026, selling an estimated $61.7K and leaving 4,167 shares worth $2.19M. The position accounts for 0.01% of the portfolio, ranked #450.

HB Wealth Management first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.8M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • HB Wealth Management held 4,167 shares of Idexx Laboratories worth $2.19M as of Q2 2026.
  • HB Wealth Management sold 110 Idexx Laboratories shares in Q2 2026, an estimated $61.7K.
  • Idexx Laboratories made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #450 holding.
  • HB Wealth Management first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • HB Wealth Management's Idexx Laboratories position peaked at $2.8M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.